Managing Tirzepatide-Related Diarrhea: Practical Strategies The first step is timing: diarrhea often improves within 24 weeks as your digestive system adjusts to the medication
Patients considering low-dose GLP-1 therapy should undergo thorough evaluation, including assessment of contraindications, baseline inflammatory markers if appropriate, and regular monitoring for adverse effects
Beta-glucan vaccine adjuvant approach for cancer treatment through immune enhancement (B-VACCIEN) in specific immunocompromised populations (review)
Additional areas of investigation Researchers are also studying semaglutide in obstructive sleep apnea (where weight loss significantly improves symptoms), heart failure with preserved ejection fraction (HFpEF), peripheral artery disease, polycystic ovary syndrome, and even addiction disorders
Research studies have shown that these GLP-1 medications are superior to other long-term FDA-approved anti-obesity medications like orlistat (Xenical, Alli), phentermine-topiramate (Qsymia), and bupropion-naltrexone (Contrave), leading to almost 20% loss of initial body weight
To date, no clinical trial has specifically evaluated BPC-157s potential to promote tumors or metastasis